Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5Polycystic Ovary Syndrome 5Insulin Resistance 2Hyperandrogenism 2Primary Dysautonomias 1Metabolic Syndrome 1Hot Flashes 1Hirsutism 1Dermatitis, Seborrheic 1Alopecia 1Adenocarcinoma 1Acne Vulgaris 1

Interventions

Gabapentin 6Acupuncture Therapy 4Venlafaxine Hydrochloride 3liposomal amphotericin B 2Tamoxifen 2Magnesium Oxide 2Isoflavones 2Citalopram 2Caspofungin 2zopiclone 1oxybutynin 1black cohosh root extract 1Zolpidem 1Vitamin B 6 1Vancomycin 1Testosterone 1Tazobactam 1Soybean Proteins 1Sodium Chloride 1Sertraline 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine 1Moxifloxacin 1Mindfulness-Based Stress Reduction 1Mindfulness 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hot Flashes × Cyproterone Acetate × Clear all
NCT00005623 2013-03-26

Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡